top of page


FDA approves blood test for the diagnosis of Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that affects the brain, gradually impairing memory, reasoning, and behaviour. The disease is marked by the accumulation of abnormal protein deposits in the brain, specifically amyloid plaques and tau tangles. These deposits disrupt neural function and ultimately lead to brain cell death. Over time, individuals lose the ability to carry out daily tasks and experience significant personality and behavioural changes

Ms. Hima Saxena
Sep 9, 20254 min read
bottom of page